Business Combinations (Tables)

6 Months Ended

Jun. 30, 2025

Business Combinations [Abstract]

Summarizes the Allocation of Aggregate Purchase Price

The following table summarizes the allocation of the aggregate purchase price of the Ambry Acquisition (in thousands):

Assets
Cash	$	20,555
Accounts receivable		62,853
Inventory		11,188
Prepaid expenses and other current assets		10,153
Total current assets	$	104,749
Property and equipment, net		38,560
Operating lease right-of-use assets		26,198
Investments and other assets		268
Customer relationships		234,000
Trade names		33,000
Developed technology - software		18,000
Developed technology - biotech		114,000
Total assets acquired	$	568,775
Liabilities
Accounts payable	$	199
Accrued expenses		28,870
Operating lease liabilities		3,008
Deferred revenue		1,347
Total current liabilities	$	33,424
Deferred revenue, less current portion		1,099
Operating lease liabilities, less current portion		23,259
Deferred tax liabilities		46,468
Other long-term liabilities		368
Total liabilities assumed	$	104,618
Net assets acquired and liabilities assumed	$	464,157
Goodwill	$	231,186
Cash consideration	$	397,296
Stock consideration		298,047
Total acquisition price	$	695,343

Schedule of Estimated Useful Lives of Identifiable Intangible Assets Acquired

Estimated useful lives of the identifiable intangible assets acquired are as follows:

	Useful Life
Customer relationships	7 years
Trade names	7 years
Developed technology - software	3 years
Developed technology - biotech	5 years

Schedule of Unaudited Pro Forma Information

The following unaudited pro forma information shows the results of the Company's operations as though the acquisition had occurred as of the beginning of the comparable period, January 1, 2024 (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2025			2024			2025			2024
Revenues	$	314,635		$	238,817		$	603,295		$	395,261
Net loss		(41,326	)		(568,490	)		(149,723	)		(586,926	)